ライフサイエンスコーパス: vitamin supplementation

1 isks, with the potential for modification by vitamin supplementation.

2 These effects are reduced by B vitamin supplementation.

3 tients receiving higher dose pemetrexed with vitamin supplementation.

4 60 infants with malformations not related to vitamin supplementation.

5 tions the risk of which is not reduced after vitamin supplementation.

6 r doses than currently available in prenatal vitamin supplementation.

7 er placebo, and PM2.5 (250 mug/m(3)) under B-vitamin supplementation (2.5 mg/d folic acid, 50 mg/d vi

8 randomly allocated to treatment groups (379 vitamin supplementation, 383 placebo).

9 ulticentre trials are needed to show whether vitamin supplementation affects the occurrence of pre-ec

10 c strategies, including pharmacologic-dose B vitamin supplementation and "high-flux" or "super-flux"

11 Vitamin supplementation and dietary intakes determined b

12 sitive women enrolled in a clinical trial of vitamin supplementation and pregnancy outcomes in Dar es

13 These effects were driven by vitamin supplementation and were negated when only exami

14 crease in overall mortality with antioxidant vitamin supplementation, at least in populations with su

15 B-vitamin supplementation attenuated PM2.5 effect on HR by

16 Our results show that B-vitamin supplementation can slow the atrophy of specific

17 em, through n-3 fatty acids plus antioxidant vitamin supplementation, could reduce the incidence of p

18 he aim of our study was to determine whether vitamin supplementation decreases the risk of venous thr

19 Combined B vitamin supplementation did not delay cognitive decline

20 Vitamin supplementation failed to prevent intimal thicke

21 nts is largely refractory to combined oral B-vitamin supplementation featuring supraphysiological dos

22 The eyes of 4 patients taking vitamin supplementation for ARMD were examined at the Un

23 ents with peripheral corneal rings receiving vitamin supplementation for ARMD.

24 d Retinol Efficacy Trial (CARET), a study of vitamin supplementation for chemoprevention of lung canc

25 be performed on a cohort of patients taking vitamin supplementation for macular degeneration that sp

26 ion of cataracts, but prospective studies of vitamin supplementation have shown little effect.

27 ne concentrations, complete blood count, and vitamin supplementation in 550 white and 212 African Ame

28 Over the same 10-year period, providing vitamin supplementation in addition to grain fortificati

29 as well tolerated at doses of 500 mg/m2 with vitamin supplementation in patients with GFR > or = 40 m

30 methionine should be considered along with B vitamin supplementation in the treatment of homocystinur

31 multiple sclerosis prevalence rates; dietary vitamin supplementation is also associated with reduced

32 faster and accurate diagnosis so that early vitamin supplementation is considered.

33 Vitamin supplementation is safe and effective in reducin

34 support the hypothesis that periconceptional vitamin supplementation may extend benefits beyond a red

35 High-dose vitamin supplementation may have some associated systemi

36 ional studies suggest that antioxidant and B vitamin supplementation may prevent atherosclerosis.

37 arotenoids, through poor diet and/or lack of vitamin supplementation, may be associated with increase

38 e view that lowering homocysteine, through B vitamin supplementation, may reduce cardiovascular risk.

39 However, the possibility that vitamin supplementation might be beneficial in women wit

40 We determine whether B vitamin supplementation mitigates PM2.5 effects on cardi

41 e (CVD) have failed to support benefits of B-vitamin supplementation on cardiovascular risk.

42 effects of B-group vitamins and antioxidant vitamin supplementation on homocysteine concentrations.

43 With vitamin supplementation, pemetrexed 600 mg/m2 was tolera

44 e important implications for the antenatal B vitamin supplementation policy in India.

45 whether homocysteine-lowering treatment by B vitamin supplementation prevents the risk of type 2 diab

46 orphisms in SEC14L2 may modify the effect of vitamin supplementation regimens on prostate cancer risk

47 tment with high-dose folic acid (FA)-based B-vitamin supplementation regimens, although controlled co

48 Treatment with pemetrexed plus cisplatin and vitamin supplementation resulted in superior survival ti

49 The effect of B-group vitamin supplementation seemed to depend on MTHFR genoty

50 High-dose vitamin supplementation should be used only in those in

51 For women without CHD, the preferred vitamin supplementation strategy would be to treat all w

52 B vitamin supplementation supports the need for enzyme cof

53 Large trials of antioxidant vitamin supplementation to prevent cancer suggest an inc

54 ents need lifelong follow-up and appropriate vitamin supplementation to prevent deficiencies.

55 d pregnant women who were participating in a vitamin supplementation trial in Tanzania were monitored

56 Further B-vitamin supplementation trials focusing on elderly subje

57 After extensive adjustments, vitamin supplementation was no longer associated with a

58 re lowered to 46 mumol/L from 244 mumol/L by vitamin supplementation, which elevated plasma folate le

59 s relevant to asthma and allergy, dietary or vitamin supplementation with antioxidants (a broad and v

60 sma pyridoxal 5'-phosphate (both sexes), and vitamin supplementation (women only).